INDIANAPOLIS -- Both behavioral and medication interventions have their place in treatment of insomnia. More>>

MINNEAPOLIS, Minn. -- Sleep specialists here reviewed the problems and alternatives for treating insomnia. More>>

MINNEAPOLIS, Minn. -- Sleep specialists here reviewed the problems and alternatives for treating insomnia. More>>

MINNEAPOLIS, Minn. -- Despite disappointing performance in clinical trials, anti-insomnia drugs that improve short-wave sleep may still have a role in helping people get a good night's rest, a specialist predicted here. More>>

SAN FRANCISCO -- A significant number of patients with major depression also suffer from chronic insomnia that hampers recovery, and treating the insomnia may improve both conditions. More>>

SAN FRANCISCO -- A significant number of patients with major depression also suffer from chronic insomnia that hampers recovery, and treating the insomnia may improve both conditions. More>>

More than one third of American adults experience persistent insomnia, the second most common complaint-after pain-in the primary care setting. However, insomnia has often been ignored, trivialized, or summarily (often erroneously) attributed to underlying or preexisting psychological problems. This handbook is the first clinically oriented text dedicated to the evaluation and treatment of insomnia. More>>

NEW ORLEANS -- The pathology behind insomnia may be more than a consequence of mental disorders such as depression, anxiety, and alcohol abuse, investigators here said. It may be a harbinger of an underlying cause. More>>

SALT LAKE CITY — Rozerem (ramelteon), a melatonin agonist, was found both safe and effective in a laboratory model of transient insomnia. More>>

SALT LAKE CITY — Rozerem (ramelteon), a melatonin agonist, was found both safe and effective in a laboratory model of transient insomnia. More>>